Loading...

PE anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_PE_122007
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE
  • BM8_PE_122007
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
123109 25 µg 35€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123110 100 µg 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Peterson T, et al. 2016. Proc Natl Acad Sci U S A. 113: 4470-4475. PubMed
  3. Zhao Y, et al. 2019. Mucosal Immunol. 1.298611111. PubMed
  4. Wang Q, et al. 2019. FASEB Bioadv. 1:609. PubMed
  5. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  6. Hasan Z, et al. 2013. Am J Physiol Lung Cell Mol Physiol. 304:221. PubMed
  7. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  8. Tan T, et al. 2019. Nat Commun. 10:3322. PubMed
  9. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  10. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  11. Qin YY, et al. 2022. Mol Ther. 30:881. PubMed
  12. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  13. Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed
  14. Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed
  15. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  16. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  17. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  18. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  19. Pan L, et al. 2022. Mol Immunol. 147:101. PubMed
  20. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  21. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  22. Campisi L, et al. 2022. Nature. 606:945. PubMed
  23. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  24. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  25. Liu M, et al. 2022. Cells. 11: . PubMed
  26. Wang Y, et al. 2022. Cell Rep. 41:111738. PubMed
  27. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  28. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  29. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  30. Glaubitz J, et al. 2023. Gut. :. PubMed
  31. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  32. Zhang K, et al. 2023. Nat Metab. 5:129. PubMed
  33. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  34. Hattori Y, et al. 2023. Cell Rep. 42:112092. PubMed
  35. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  36. Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed
  37. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  38. Morris CR, et al. 2022. Mucosal Immunol. 15:977. PubMed
  39. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  40. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  41. Huang Q, et al. 2023. Immun Inflamm Dis. 11:e779. PubMed
  42. Li L, et al. 2023. iScience. 26:106095. PubMed
  43. Zhang X, et al. 2023. Heliyon. 9:e13490. PubMed
  44. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  45. Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed
  46. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  47. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  48. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  50. Chen S, et al. 2023. J Immunother Cancer. 11:. PubMed
  51. Duan JL, et al. 2023. Nat Aging. 3:258. PubMed
  52. Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed
  53. Yang Y, et al. 2023. Diagnostics (Basel). 13:. PubMed
  54. Tang M, et al. 2023. Sci Adv. 9:eade6624. PubMed
  55. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  56. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  57. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  58. Peng, P., Fan, S., et al. 2025. Mater Today Bio. 35(0),102601. PubMed
  59. Karki R, et al. 2016. Nature. 10.1038/nature20597. PubMed
  60. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  61. Kloepper J, et al. 2016. Proc Natl Acad Sci U S A. 113: 4476-4481. PubMed
  62. O'Donnell C, et al. 2015. Br J Cancer. 114: 37 - 43. PubMed
  63. Maltby S, et al. 2014. J Immunol. 193:4072. PubMed
  64. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  65. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  66. Wietecha MS, et al. 2020. Nat Commun. 2.266666667. PubMed
  67. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  68. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  69. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  70. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  71. Yildirim Z, et al. 2022. EMBO Mol Med. 14:e15344. PubMed
  72. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  73. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  74. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  75. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  76. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  77. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  78. Huang J, et al. 2021. Immunity. 54(4):673-686.e4. PubMed
  79. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  80. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  81. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  82. Yu S, et al. 2016. J Immunol. 197: 256 - 265. PubMed
  83. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  84. Guo HX, et al. 2018. World J Gastroenterol. 24:1779. PubMed
  85. Karki R et al. 2018. Cell. 173(4):920-933 . PubMed
  86. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  87. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  88. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  89. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  90. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  91. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  92. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  93. Matsushita Y, et al. 2021. J Bone Miner Res. 36:1145. PubMed
  94. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  95. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  96. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  97. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  98. Li T, et al. 2016. Cell Death Dis. 7:e2258. PubMed
  99. Elbaz M, et al. 2015. Mol Oncol. 9: 906-919. PubMed
  100. Tang E, et al. 2015. J Lipid Res. 56:358. PubMed
  101. Harel M, et al. 2020. Cell. 179(1):236-250.e18.. PubMed
  102. Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
  103. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  104. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  105. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  106. Truax AD et al. 2018. Cell host & microbe. 24(3):364-378 . PubMed
  107. Rashid K, et al. 2018. Sci Rep. 8:9023. PubMed
  108. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  109. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  110. Gopinathan G, et al. 2022. Mol Cancer Ther. 21:1030. PubMed
  111. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  112. Yu X, et al. 2021. Nature. 594:560. PubMed
  113. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  114. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  115. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  116. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  117. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  118. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  119. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  120. Liu Z, et al. 2015. Biol Reprod. 92:63. PubMed
  121. Nasser MW, et al. 2015. Cancer Res . 75: 974-985. PubMed
  122. Liu Y, et al. 2015. Sci Rep. 5:17215. PubMed
  123. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  124. Tencati M, Tapping R 2016. Infect Immun . 84: 2904 - 2913. PubMed
  125. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  126. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  127. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  128. Liao Y, et al. 2017. Virol J. 10.1186/s12985-017-0801-x. PubMed
  129. Dong G, et al. 2017. Biochim Biophys Acta. 10.1016/j.bbadis.2017.08.005. PubMed
  130. Tamura R, et al. 2017. Inflamm Regen. 36:26:00. PubMed
  131. Nabeta HW, et al. 2022. Front Cell Infect Microbiol. 12:976033. PubMed
  132. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  133. Dignum T, et al. 2021. Cell Rep. 36:109675. PubMed
  134. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  135. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  136. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  137. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  138. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  139. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  140. Markov SD, et al. 2021. Mol Cancer Ther. 20:2457. PubMed
  141. Sun P, et al. 2021. J Invest Dermatol. 141:1542. PubMed
  142. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  143. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  144. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  145. Kovacs L, et al. 2020. PLoS One. 15:e0240455. PubMed
  146. Izquierdo-Useros N, et al. 2014. J Immunol . 192:4852-4858. PubMed
  147. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  148. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  149. Glass A, et al. 2013. J Immunol. 190:4830. PubMed
  150. Lumbroso D, et al. 2018. Front Immunol. 9:358. PubMed
  151. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  152. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  153. Wu X, et al. 2021. Elife. 10:. PubMed
  154. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  155. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  156. Cheng XS, et al. 2020. J Cell Mol Med. 24:8391. PubMed
  157. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  158. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  159. Yin T, et al. 2016. Sci Rep. 18:19534. PubMed
  160. Mitsuhashi A, et al. 2015. Nat Commun. 6: 8792. PubMed
  161. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  162. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  163. Das LM, et al. 2019. Autophagy. 15:813. PubMed
  164. Pelka K, et al. 2018. Immunity. 48:911. PubMed
  165. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  166. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  167. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  168. Ma K, et al. 2021. J Leukoc Biol. 110:927. PubMed
  169. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  170. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  171. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  172. Wang H, et al. 2021. Malar J. 20:249. PubMed
  173. Wang Q, et al. 2020. Res Sq. . PubMed
  174. Hofbauer D, et al. 2021. Immunity. 54(8):1772-1787.e9. PubMed
  175. Lin J, et al. 2017. Sci Rep. 7:41722. PubMed
  176. Chen W, et al. 2016. J Immunol. 197: 3554 - 3565. PubMed
  177. Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
  178. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  179. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  180. Hu M, et al. 2021. J Clin Invest. 131:. PubMed
  181. Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed
  182. Li N, et al. 2021. eLife. 10:00. PubMed
  183. Penninger P, et al. 2021. STAR Protocols. 2(1):100352. PubMed
  184. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  185. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  186. Iizasa E, et al. 2021. Nat Commun. 12:2299. PubMed
  187. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  188. Wang C, et al. 2017. J Ethnopharmacol. 10.1016/j.jep.2017.06.014. PubMed
  189. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  190. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  191. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  192. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  193. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  194. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  195. Kuai Y, et al. 2020. Theranostics. 5.099305556. PubMed
  196. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  197. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  198. Michaud J, et al. 2017. BMC Microbiology . 10.1186/s12866-017-1036-0. PubMed
  199. Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed
  200. Sun T, et al. 2017. Mucosal Immunol. 0.954861111. PubMed
  201. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  202. Cho K, et al. 2021. iScience. 24:103117. PubMed
  203. Ma S, et al. 2022. Cell Rep. 38:110520. PubMed
  204. Sharma S, et al. 2021. Pathophysiology. 28:501. PubMed
  205. McDonald B, et al. 2020. Cell Host Microbe. 28(5):660-668.e4. PubMed
  206. Devi S, et al. 2021. Immunity. 54(6):1219-1230.e7. PubMed
  207. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  208. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  209. Bai B, et al. 2021. Theranostics. 11:6225. PubMed
  210. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  211. Pashover-Schallinger E, et al. 2012. FASEB J. 26:3891. PubMed
  212. Min C, et al. 2020. Cell Death Dis. 0.847916667. PubMed
  213. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  214. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  215. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  216. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  217. Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
  218. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  219. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  220. Fields L, et al. 2021. Mol Ther. 29:2554. PubMed
  221. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  222. Murr NJ, et al. 2021. Nutrients. 13:. PubMed
  223. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  224. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  225. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  226. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  227. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  228. Zhang S, et al. 2014. Eur J Pharmacol. 733:45. PubMed
  229. Kumagai S, et al. 2016. Cardiovasc Res. 109: 272 - 282. PubMed
  230. Ikezoe K, et al. 2016. Sci Rep. 6: 25781. PubMed
  231. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  232. Li B, et al. 2019. Oncol Rep. 41:608. PubMed
  233. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  234. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  235. Fu Y, et al. 2021. Front Cell Dev Biol. 9:689727. PubMed
  236. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
  237. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  238. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  239. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  240. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  241. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  242. Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
  243. Kolodkin-Gal D, et al. 2021. Gut. Online ahead of print. PubMed
  244. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  245. Yahuafai J, et al. 2014. J Control Release. 28:192. PubMed
  246. Sun X, et al. 2020. Cell Metabolism. 31(1):189-206.e8.. PubMed
  247. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  248. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  249. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  250. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  251. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  252. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  253. Lamb T, et al. 2022. Toxics. 10:. PubMed
  254. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  255. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  256. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  257. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  258. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  259. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  260. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  261. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  262. Maniati E, et al. 2020. Cell Rep. 30:525. PubMed
  263. Han MS, et al. 2020. Proc Natl Acad Sci U S A. 117:2751. PubMed
  264. Sundar I, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.09.157. PubMed
  265. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  266. Wang S, et al. 2022. J Inflamm Res. 14:7107. PubMed
  267. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  268. Yang H, et al. 2020. Arterioscler Thromb Vasc Biol. 40:e350. PubMed
  269. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  270. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  271. Kang M, et al. 2021. Front Cell Dev Biol. 8:596622. PubMed
  272. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  273. Valkenburg S, et al. 2016. Sci Rep. 6:22666. PubMed
  274. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  275. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  276. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  277. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  278. William M, et al. 2018. J Immunol. 200:4102. PubMed
  279. Ayturk UM, et al. 2020. J Bone Miner Res. 35:1981. PubMed
  280. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  281. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  282. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  283. Gao X, et al. 2021. Nature. 589:591. PubMed
  284. Lee SA, et al. 2021. Cells. 10:. PubMed
  285. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  286. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  287. Xiang Y, et al. 2014. Proc Natl Acad Sci U S A. . PubMed
  288. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  289. Peng X, et al. 2015. J Immunol. 195: 2797-2805. PubMed
  290. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  291. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  292. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  293. Xu M, et al. 2020. Cell. 178(6):1478-1492.e20.. PubMed
  294. Wang Q, et al. 2020. Respir Res. 0.981944444. PubMed
  295. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  296. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  297. Zhang F, et al. 2021. J Immunol Res. 2021:5521051. PubMed
  298. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  299. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  300. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  301. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  302. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  303. Silva-Cayetano A, et al. 2020. Med. 2(3):243-262.e8. PubMed
  304. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  305. Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed
  306. Yin T, et al. 2015. J Immunol. 194:429. PubMed
  307. Zhang J, et al. 2014. J Immunol. 193:5149. PubMed
  308. Baker GJ, et al. 2020. Cell Syst. 0.647222222. PubMed
  309. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  310. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  311. Perrotta C, et al. 2018. Front Immunol. 9:1186. PubMed
  312. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  313. Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed
  314. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  315. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  316. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  317. Nakayama Y, et al. 2020. Proc Natl Acad Sci U S A. 117:14365. PubMed
  318. Horwitz E, et al. 2014. Cancer Discovery. 4:730. PubMed
  319. Wang Y, et al. 2015. Sci Rep. 5:16973. PubMed
  320. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  321. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  322. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  323. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  324. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  325. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  326. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  327. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  328. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  329. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  330. Xiao M, et al. 2022. Mol Oncol. 16:1026. PubMed
  331. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  332. Gawish R, et al. 2022. Elife. 11:. PubMed
  333. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  334. Wang X, et al. 2020. Immunity. 328:52. PubMed
  335. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  336. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  337. Feng L, et al. 2014. Biochem Pharmacol. 89:109. PubMed
  338. Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed
  339. Samir P, et al. 2019. Nature. 573:590. PubMed
  340. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  341. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  342. Han J, et al. 2022. Cell Discov. 8:122. PubMed
  343. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  344. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  345. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  346. Witas R, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_893498 (BioLegend Cat. No. 123109)
AB_893486 (BioLegend Cat. No. 123110)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
F4/80
Specificity Alt (DOES NOT SHOW ON TDS):
F4/80
App Abbreviation (DOES NOT SHOW ON TDS):
FC
Hidden Names (DOES NOT SHOW ON TDS):
F4, F80, Macrophage, Myeloid Dendritic Cell, Plasmacytoid Dendritic Cell
UniProt
View information about F4/80 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark Red™ 718 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Spark Blue™ 574 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
PE/Fire™ 640 anti-mouse F4/80 BM8 FC
PerCP/Fire™ 806 anti-mouse F4/80 BM8 FC
Go To Top Version: 2    Revision Date: 10/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account